July 15, 2017 Uncategorized No Comments

Cardiocity’s latest RhythmPad2 is on full clinical trial at Ashford & St Peter’s Hospital in the UK. The NIHR study has a cohort of 750 all ages ranges using the RhythmPad2 technology to measure the ECG from the finger tips with a new unique level of accuracy previously unseen. St Peter’s Deputy Director of Research Dr Isaac John commented “It is great that we have been able to extend our long running partnership with Cardiocity and to undertake the trialing of this cutting edge technology.”

Written by Chris Crockford